Particle.news

Download on the App Store

FDA Reinstates Zepto’s Dharavi Warehouse License After Compliance Report

A thorough reinspection confirmed corrective actions on fungal growth, storage temperatures, hygiene shortcomings

Image
Image

Overview

  • The Food and Drug Administration suspended Zepto’s Dharavi warehouse licence on June 1 after inspectors uncovered fungal contamination, expired products and unsanitary storage conditions
  • Zepto appealed the suspension and on June 13 the state food safety agency conducted a detailed reinspection, reviewing the company’s audit, water tests and photographic evidence
  • An appellate authority revoked the suspension following Zepto’s submission of a compliance report demonstrating corrective measures to meet regulatory standards
  • The warehouse operated by licensee Drogheria Sellers under Zepto’s B2B model resumed order fulfilment on June 14
  • Observers warn that thin margins and commission fees for warehouse partners can constrain maintenance spending, prompting heightened regulatory scrutiny of quick commerce operations